| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |